Valuation: Navamedic ASA

Market Cap 385M 39.82M 34.81M 32.19M 29.54M 55.9M 3.84B 56.88M 384M 151M 1.87B 150M 146M 6.47B P/E 2026 *
-292x
P/E 2027 * 36.1x
Enterprise Value 505M 52.24M 45.66M 42.23M 38.75M 73.33M 5.03B 74.61M 504M 198M 2.46B 196M 192M 8.49B EV / Sales 2026 *
0.86x
EV / Sales 2027 * 0.73x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 week-3.89%
Current month-1.83%
1 month-5.59%
3 months-17.69%
6 months-26.38%
Current year-32.56%
1 week 16.05
Extreme 16.05
16.65
1 month 15.7
Extreme 15.7
17.45
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 31/12/2018
Director of Finance/CFO - 31/12/2025
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 31/05/2022
Director/Board Member - 31/05/2023
Director/Board Member 60 31/05/2024
Date Insider Type Main position Quantity % Market Cap.
19/12/24 Buy

Chief Operating Officer

10,267 0.0581%
09/09/24 Fiscal year

Executive/Senior Manager

75,000 0.4302%
09/09/24 Fiscal year

Chief Executive Officer

80,000 0.4589%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.89%-27.70%-57.98% 39.82M
+1.08%-3.93%+48.03%+160.13% 1,043B
+1.19%-3.52%+51.70%+56.36% 602B
+4.21%+1.79%+33.48%+87.04% 449B
+0.24%-1.60%+28.87%+23.49% 327B
+0.80%-0.23%+32.85%+46.02% 279B
-0.64%-2.59%+21.23%+22.56% 264B
+3.70%+2.19%+24.27%+63.38% 201B
+3.49%+1.08%+24.08%+76.58% 169B
+1.29%+3.67%+2.15%-30.78% 143B
Average +0.85%-1.01%+23.90%+44.68% 347.71B
Weighted average by Cap. +0.94%-1.82%+37.30%+82.75%

Financials

2026 *2027 *
Net sales 588M 60.82M 53.16M 49.16M 45.11M 85.38M 5.86B 86.87M 586M 230M 2.86B 228M 223M 9.88B 643M 66.57M 58.19M 53.81M 49.38M 93.46M 6.41B 95.08M 642M 252M 3.13B 250M 245M 10.81B
Net income -1.5M -155K -135K -125K -115K -217K -14.9M -221K -1.49M -586K -7.28M -581K -568K -25.13M 10.7M 1.11M 968K 895K 821K 1.55M 107M 1.58M 10.67M 4.19M 52.09M 4.16M 4.07M 180M
Net Debt 120M 12.41M 10.85M 10.04M 9.21M 17.43M 1.2B 17.73M 120M 47.02M 584M 46.62M 45.6M 2.02B 87.4M 9.04M 7.9M 7.31M 6.71M 12.69M 871M 12.91M 87.17M 34.24M 425M 33.96M 33.21M 1.47B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
16/07/26 NOK 16.05 0.00% 10
15/07/26 NOK 16.05 -0.93% 2,151
14/07/26 NOK 16.20 -1.52% 5,258
13/07/26 NOK 16.45 +0.30% 1,157
10/07/26 NOK 16.40 -1.80% 22,261
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.05NOK
Average target price
23.50NOK
Spread / Average Target
+46.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock